Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.0 is listed as the current version, replacing v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing v3.4.1. No study content or page functionality appears to be affected.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page adds Revision: v3.4.1 and removes the earlier entries Revision: v3.4.0 and the government funding/operating-status notice.SummaryDifference0.4%

- Check63 days agoChange DetectedA government funding lapse notice has been added at the top of the page, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

- Check70 days agoChange DetectedAdditions include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' entry, 'No FEAR Act Data', and a 'Revision: v3.4.0' label. Deletions remove 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older 'Revision: v3.3.4' label.SummaryDifference0.2%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.